# Duobrii

NDC: 0187-0653
Generic name: halobetasol propionate and tazarotene
Labeler / Manufacturer: Bausch Health US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: LOTION
Routes: TOPICAL
Marketing started: 20190425

FDA application: NDA209354

## Active ingredients

- HALOBETASOL PROPIONATE: .1 mg/g
- TAZAROTENE: .45 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0187-0653"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0187-0653
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3f0cdc0-69fd-43d1-baf2-d776a3a20715